High loading-dose of dupilumab resulted in rapid disease control in pediatric patients with atopic dermatitis

BACKGROUND: The real-world experience of dupilumab in Chinese is limited, and the initial loading dose has not yet been deeply explored in patients aged <6 years. OBJECTIVE: To explore the efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis and investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ao, Zhou, Yuan, Luo, Yang, Gao, Yingxia, Chen, Jingsi, Li, Wei, Luo, Xiaoyan, Yao, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157040/
https://www.ncbi.nlm.nih.gov/pubmed/37153599
http://dx.doi.org/10.3389/fimmu.2023.1160710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157040/
https://www.ncbi.nlm.nih.gov/pubmed/37153599
http://dx.doi.org/10.3389/fimmu.2023.1160710

Ejemplares similares